25.11

2.57% 0.5639

Pulse Biosciences Inc (PLSE)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$24.55

Aprire:

$25

Volume 24 ore:

297.61K

Relative Volume:

0.92

Capitalizzazione di mercato:

$1.73B

Reddito:

$751.00K

Utile/perdita netta:

$-74.57M

Rapporto P/E:

-22.77

EPS:

-1.1031

Flusso di cassa netto:

$-54.46M

1 W Prestazione:

+31.97%

1M Prestazione:

+7.61%

6M Prestazione:

+85.42%

1 anno Prestazione:

+46.48%

Intervallo 1D:

$24.60

$25.62

Intervallo di 1 settimana:

$20.74

$27.98

Portata 52W:

$12.56

$27.98

Pulse Biosciences Inc Stock (PLSE) Company Profile

Nome

Pulse Biosciences Inc

Settore

Healthcare (1105)

Industria

Medical Instruments & Supplies (56)

Telefono

510-906-4600

Indirizzo

3957 POINT EDEN WAY, HAYWARD, CA

Dipendente

116

Cinguettio

@PulseBioNPS

Prossima data di guadagno

2026-05-14

Ultimi documenti SEC

PLSE's Discussions on Twitter

Compare PLSE vs ISRG, BDX, ALC, MDLN, RMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
PLSE Pulse Biosciences Inc	25.00	1.70B	751.00K	-74.57M	-54.46M	-1.1031
ISRG Intuitive Surgical Inc	437.90	149.15B	10.58B	3.00B	2.83B	8.2437
BDX Becton Dickinson Co	142.64	39.53B	21.37B	1.41B	3.07B	3.9437
ALC Alcon Inc	65.57	31.04B	10.63B	819.00M	1.59B	1.6577
MDLN Medline Inc	35.53	30.60B	29.14B	1.07B	1.05B	1.1956
RMD Resmed Inc	204.73	29.28B	5.54B	1.52B	1.74B	10.37

Pulse Biosciences Inc Stock (PLSE) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-01-30	Iniziato	Mizuho	Outperform
2025-07-07	Iniziato	Oppenheimer	Outperform
2021-07-27	Iniziato	Stephens	Overweight
2021-03-11	Iniziato	Maxim Group	Buy
2021-01-26	Reiterato	H.C. Wainwright	Buy
2020-05-12	Aggiornamento	H.C. Wainwright	Neutral → Buy
2020-02-14	Downgrade	H.C. Wainwright	Buy → Neutral
2019-02-25	Iniziato	H.C. Wainwright	Buy

Mostra tutto

Pulse Biosciences Inc Borsa (PLSE) Ultime notizie

09:46 AM

PLSE accelerates cardiac catheter program after breakthrough AFib data - MSN

09:46 AM

May 17, 2026

Pulse Biosciences CEO Buys 15,000 Shares: SEC Filing Details | May 2026News and Statistics - IndexBox

May 17, 2026

Pulse Biosciences CEO Bought 15,000 Company Shares. Here's What That Means for Investors. - Yahoo Finance

May 17, 2026

May 16, 2026

(SEC Amendment) Pulse Biosciences(PLSE.US) 10% Shareholder Buys US$13 Million in Common Stock - Moomoo

May 16, 2026

May 15, 2026

Pulse Biosciences director Robert W. Duggan acquires $13m in stock - Investing.com India

May 15, 2026

Director Robert Duggan buys 660K Pulse Biosciences (PLSE) shares - Stock Titan

May 15, 2026

May 14, 2026

Pulse Bio rises after over $13M insider buying - MSN

May 14, 2026

Pulse Biosciences stock hits 52-week high at 26.33 USD By Investing.com - Investing.com Nigeria

May 14, 2026

Pulse Biosciences, Inc. Q1 2026 Financial Report – Revenue, Losses, and Key Corporate Updates - Minichart

May 14, 2026

Pulse Biosciences Announces Clinical Data From nPulse Vybrance System Study - Medical Product Outsourcing

May 14, 2026

Pulse Biosciences stock hits 52-week high at 26.33 USD - Investing.com India

May 14, 2026

Pulse Biosciences stock (US73242P1030): Q1 2026 net loss widens to $18.6M on early commercialization - AD HOC NEWS

May 14, 2026

PULSE BIOSCIENCES, INC. 1Q 2026: Revenue $401K, EPS ($0.27) — 10-Q Summary - TradingView

May 14, 2026

Pulse Biosciences Inc at Bank of America Global Healthcare Conference Transcript - GuruFocus

May 14, 2026

Pulse Biosciences (NASDAQ: PLSE) Q1 2026 results, cash burn and AF strategy - Stock Titan

May 14, 2026

May 13, 2026